Compound blue nevus: A misleading pigmented melanocytic tumor.
dermatology
genetics
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
16
09
2021
revised:
10
11
2021
accepted:
12
11
2021
entrez:
26
1
2022
pubmed:
27
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Compound blue nevus had clinical and histological similarities with other heavily pigmented melanocytic tumor, like the pigmented epithelioid melanocytoma. Distinctive genomic aberrations have allowed differentiating it. The defining characteristic of blue nevi family is the presence of activating mutations in the G protein α-subunits, GNAQ and GNA11.
Identifiants
pubmed: 35079400
doi: 10.1002/ccr3.5311
pii: CCR35311
pmc: PMC8766608
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e05311Informations de copyright
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors have no potential conflict of interest to disclose.
Références
Melanoma Res. 2015 Aug;25(4):295-301
pubmed: 25933206
J Am Acad Dermatol. 2002 Jan;46(1):85-9
pubmed: 11756951
Australas J Dermatol. 2019 Nov;60(4):336-338
pubmed: 30724334
Virchows Arch. 2020 Mar;476(3):439-443
pubmed: 31754815
Dermatopathology (Basel). 2019 Mar 5;6(1):20-22
pubmed: 31049319
Arch Dermatol. 1990 Oct;126(10):1330-3
pubmed: 2221938
Am J Surg Pathol. 2019 Oct;43(10):1368-1376
pubmed: 31162285
Clin Lab Med. 2017 Sep;37(3):401-415
pubmed: 28802492